TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that Marvin Slosman, Chief Executive Officer, will deliver a company update presentation at the 23rd Annual Needham Virtual Healthcare Conference, which is being held April 8-11, 2024.
Presentation details:
| Date: | Wednesday, April 10th |
| Time: | 8:00-8:40 AM ET |
| Webcast: | https://wsw.com/webcast/needham138/nspr/2290730, or on the Events section of the company’s Investor Relations website at https://www.inspiremd.com/en/events/. |
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on the Nasdaq under the ticker symbol NSPR.
We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.
Investor Contacts:
Craig Shore
Chief Financial Officer
InspireMD, Inc.
888-776-6804
craigs@inspiremd.com
Chuck Padala, Managing Director
LifeSci Advisors
646-627-8390
chuck@lifesciadvisors.com
investor-relations@inspiremd.com
Winter Park, Florida--(Newsfile Corp. - April 7, 2025) - Adia Nutrition Inc. (OTC Pink: ADIA),…
Toronto, Ontario--(Newsfile Corp. - April 7, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE:…
Subcutaneous (SC) amivantamab offers patients greater convenience, reducing administration time from hours to minutes and…
Expanding Regional Expertise and Localized Solutions to Meet the Growing Demands of Asia-Pacific Healthcare.CRANSTON, R.I.,…
NEW YORK and WOONSOCKET, R.I., April 07, 2025 (GLOBE NEWSWIRE) -- Surplus Solutions LLC (“Surplus…
Key structural and mechanistic insights into BSEP transporter mutations that lead to improper protein folding…